Preclinical research has demonstrated that nanoparticles and macromolecules can accumulate in solid tumors due to the enhanced permeability and retention effect. However, drug loaded nanoparticles often fail to show increased efficacy in clinical trials. A better understanding of how tumor heterogeneity affects nanoparticle accumulation could help elucidate this discrepancy and help in patient selection for nanomedicine therapy. Here we studied five human tumor models with varying morphology and evaluated the accumulation of 100 nm polystyrene nanoparticles. Each tumor model was characterized in vivo using micro-computed tomography, contrast-enhanced ultrasound and diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging....
The enhanced permeability and retention (EPR) effect is variable depending on nanoparticle propertie...
Nanoparticles can provide significant improvements in the diagnosis and treatment of cancer. How nan...
The development of nanoparticle-based targeted therapeutics for the treatment of cancer requires a w...
Preclinical research has demonstrated that nanoparticles and macromolecules can accumulate in solid ...
Vascular targeting of malignant tissues with systemically injected nanoparticles (NPs) holds promise...
To improve the clinical translation of anti-cancer nanomedicines, it is necessary to begin building ...
Nanoparticle tumor accumulation relies on a key mechanism, the enhanced permeability and retention (...
Tumors present numerous biobarriers to the successful delivery of nanoparticles. Decreased blood flo...
The development of nanoparticle-based targeted therapeutics for the treatment of cancer requires a w...
The development of nanoparticle-based targeted therapeutics for the treatment of cancer requires a w...
Nanoparticle tumor accumulation relies on a key mechanism, the enhanced permeability and retention (...
International audienceNanoparticles are useful tools in oncology because of their capacity to passiv...
The enhanced permeability and retention (EPR) effect is used extensively for the passive targeting o...
As the enhanced permeation and retention (EPR) effect continues to be a controversial topic in nanom...
As the enhanced permeation and retention (EPR) effect continues to be a controversial topic in nanom...
The enhanced permeability and retention (EPR) effect is variable depending on nanoparticle propertie...
Nanoparticles can provide significant improvements in the diagnosis and treatment of cancer. How nan...
The development of nanoparticle-based targeted therapeutics for the treatment of cancer requires a w...
Preclinical research has demonstrated that nanoparticles and macromolecules can accumulate in solid ...
Vascular targeting of malignant tissues with systemically injected nanoparticles (NPs) holds promise...
To improve the clinical translation of anti-cancer nanomedicines, it is necessary to begin building ...
Nanoparticle tumor accumulation relies on a key mechanism, the enhanced permeability and retention (...
Tumors present numerous biobarriers to the successful delivery of nanoparticles. Decreased blood flo...
The development of nanoparticle-based targeted therapeutics for the treatment of cancer requires a w...
The development of nanoparticle-based targeted therapeutics for the treatment of cancer requires a w...
Nanoparticle tumor accumulation relies on a key mechanism, the enhanced permeability and retention (...
International audienceNanoparticles are useful tools in oncology because of their capacity to passiv...
The enhanced permeability and retention (EPR) effect is used extensively for the passive targeting o...
As the enhanced permeation and retention (EPR) effect continues to be a controversial topic in nanom...
As the enhanced permeation and retention (EPR) effect continues to be a controversial topic in nanom...
The enhanced permeability and retention (EPR) effect is variable depending on nanoparticle propertie...
Nanoparticles can provide significant improvements in the diagnosis and treatment of cancer. How nan...
The development of nanoparticle-based targeted therapeutics for the treatment of cancer requires a w...